Login / Signup

Intrathecal treatment trial of rituximab in progressive MS: results after a 2-year extension.

Joakim BergmanJoachim BurmanTommy BergenheimAnders Svenningsson
Published in: Journal of neurology (2020)
EudraCT; 2008-002626-11 and 2012-000721-53.
Keyphrases
  • multiple sclerosis
  • mass spectrometry
  • study protocol
  • ms ms
  • phase iii
  • randomized controlled trial
  • phase ii
  • combination therapy
  • open label
  • smoking cessation